Fig. 4From: Ectoderm-derived frontal bone mesenchymal stem cells promote traumatic brain injury recovery by alleviating neuroinflammation and glutamate excitotoxicity partially via FGF1FbMSC application promotes the recovery of axonal injury in TBI mice. MAP2 immunofluorescence and fluorescence intensity quantification in peri-impact area and hippocampus in each group at 4 d (a, b) and 28 d (c, d) post-injury. Scale bar, 20 μm. e Representative 3D reconstruction images of MAP2 staining in hippocampus in each group at 4 d post-injury. Scale bar, 150 μm. Doublecortin (DCX) immunofluorescence image (f) and fluorescence intensity quantification (g) in each group at 14 d post-injury. Scale bar, 20 μm. h Expression of BDNF was detected by qRT-PCR at 14 d post-injury. (n = 3–4 mice per group; Data are presented as the mean ± standard error; *, **, ***, and **** indicate significance at p < 0.05, p < 0.01, p < 0.001, and p < 0.0001, respectively.)Back to article page